WHO Panel Recommends World Move Forward With Global Polio Vaccine Switch, Despite Challenges, Risks

Center for Strategic & International Studies’ “Smart Global Health Blog”: WHO’s SAGE Gives Final Nod to April Polio Vaccine Switch
Nellie Bristol, senior fellow with the CSIS Global Health Policy Center, discusses the WHO Strategic Advisory Group of Experts (SAGE) on Immunization’s recommendation that the world move forward with an April 2016 switch from trivalent to bivalent oral polio vaccines (OPV), as “the first stage in eventual worldwide withdrawal of all OPV and replacement with inactivated poliovirus vaccine (IPV).” Bristol notes the challenges and risks of making the switch, such as the possibility of vaccine-derived outbreaks (10/27).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.